IO Informatics and Sage-N Research Announce Partnership
News Mar 08, 2012
IO Informatics announces a strategic partnership with Sage-N Research, Inc. that includes the integration of Sage-N's SORCERER™ Enterprise with the IO Informatics' Sentient software suite. The combination of these technologies creates a Semantic application framework that has been used to quickly develop a highly specialized, large-scale application that leverages mass-spectrometry based Proteomics with unmatched content enrichment, interoperability, and flexibility only possible with semantic data integration.
"One application of this novel approach is to identify peptides from different microorganism with common mechanism of actions, and to categorize them as potential biomarkers, and it also has the capability to detect microbial threats prior to onset of disease symptoms," said Ali Pervez, Vice President of Marketing at Sage-N Research.
This new alliance was announced at the Human Proteome Organization (HUPO) 8th Annual Conference: The Future of Proteomics in San Francisco, CA. Using customer data and the newly combined technologies, Dr. Erich A. Gombocz, CSO of IO Informatics, highlighted the workflow in a talk entitled, "A novel approach to recognize peptide functions in microorganisms: Establishing systems biology-based relationship networks to better understand disease causes and prevention."
"Future applications of this technology will enable automated screening for biological threats, to characterize origin and type of disease and to develop preventive measures (drugs or vaccines) effective for several classes of microorganism," said Robert Stanley, President of IO Informatics.
Algorithm Speeds Up Medical Image Analysis 1000 TimesNews
Medical image registration is a common technique that involves overlaying two images, such as magnetic resonance imaging (MRI) scans, to compare and analyze anatomical differences in great detail. Researchers have described a machine-learning algorithm that can register brain scans and other 3-D images more than 1,000 times more quickly using novel learning techniques.
Synthetic DNA Shuffling Enzyme Outpaces Natural CounterpartNews
A new synthetic enzyme, crafted from DNA rather than protein, flips lipid molecules within the cell membrane, triggering a signal pathway that could be harnessed to induce cell death in cancer cells. Researchers say their lipid-scrambling DNA enzyme is the first in its class to outperform naturally occurring enzymes – and does so by three orders of magnitudeREAD MORE
Antarctic Worm and Machine Learning Help Identify Cerebral Palsy EarlierNews
A research team has released a study in the peer-reviewed journal BMC Bioinformatics showing that DNA methylation patterns in circulating blood cells can be used to help identify spastic cerebral palsy (CP) patients. The technique which makes use of machine learning, data science and even analysis of Antarctic worms, raises hopes for earlier targeted CP therapies.